Phage
Phase 1Biologic
Phage is one of 5 biologic programs targeting Chronic constipation. It is currently in Phase 1.
2
Indications
4
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Chronic Constipation
#DrugCompanyPhaseTrials
1Resotran
TakedaApproved
Golytely
BayerApproved
Phage
OOttawa Hospital Research Institute
Phase 1
Ornidazole
AAssistance Publique - Hôpitaux de Paris
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Efficacy1 trial
Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes
Withdrawn·—·Phase 1/2·NCT04289948
Chronic constipation1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Phage. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details